Skip to main content
Article thumbnail
Location of Repository

Loss of Digits after Trauma in a Patient with Systemic Lupus Erythematosus

By Heidee Villanueva, Marius Tijunelis, Sharon Shapiro and Sean O. Henderson

Abstract

A 19-year-old female with Systemic Lupus Erythematosus (SLE) presented with ischemia of her left hand following trauma. Medical therapy was initiated but failed to improve her symptoms, and revision amputation was ultimately performed. The patient’s final diagnosis was digital ischemia due to secondary Raynaud’s Phenomenon (RP). The authors discuss diagnosis, complications, and treatment of this relatively uncommon disorder. The authors report this case in order to discuss how secondary RP can be complicated by ischemia and the multidisciplinary approach that needs to take place to prevent the latter from occurring

Topics: Case Report
Publisher: Department of Emergency Medicine, University of California, Irvine School of Medicine
OAI identifier: oai:pubmedcentral.nih.gov:2672233
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1985). A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud’s phenomenon. J Rheumatol.
    2. (1987). A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud’s phenomenon. Vasa Suppl.
    3. (1997). Amlodipine in the treatment of Raynaud’s phenomenon. A doubleblind placebo-controlled crossover study. Clin Drug Invest.
    4. (2005). Calcium channel blockers for primary Raynaud’s phenomenon: a meta-analysis. Rheumatology(Oxford).
    5. (1993). Cervicothoracic sympathectomy for Raynaud’s syndrome. Int Angiol.
    6. (1996). Current management of Raynaud’s syndrome. Adv Surg.
    7. (2003). Differentiation of primary and secondary Raynaud’s disease by carotid arterial stiffness. Eur J Vasc Endovasc Surg.
    8. (2000). Long-term low molecular weight heparin therapy for severe Raynaud’s phenomenon: a pilot study. Clin Exp Rheumatol.
    9. (2003). Management of Raynaud’s phenomenon and digital ischemic lesions in scleroderma. Rheum Dis Clin N Am.
    10. (1983). Partial finger loss: an indicator of severe connective tissue disease with overlap features.
    11. (1986). placebo-controlled study of prazoxin in Raynaud’s phenomenon. Clin Pharmacol Ther.
    12. (1988). Prospective study of the evolution of Raynaud’s phenomenon.
    13. (2005). Raynaud’s phenomenon in mixed connective tissue disease. Rheum Dis Clin North Am.
    14. (2006). Sildenafil for the treatment of Raynaud’s phenomenon.
    15. (1958). Sympathectomy for Raynaud’s phenomenon; follow-up study of 70 women with Raynaud’s disease and 54 women and secondary Raynaud’s phenomenon. Circulation.
    16. (1990). The phenomenon, syndrome and disease of Maurice Raynaud.
    17. (1994). Transthoracic endoscopic sympathectomy for hyperhidrosis and Raynaud’s phenomenon. Eur J Vasc Surg.
    18. (1984). Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.